These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Dark effect of 8-methoxypsoralen (8-MOP) on lymphocytes. Lischka G; Decker E Arch Dermatol Res; 1978 May; 261(3):267-72. PubMed ID: 686810 [TBL] [Abstract][Full Text] [Related]
3. Photochemotherapy (PUVA) and psoriasis: comparison of 8-MOP and 8-MOP/5-MOP. Langner A; Wolska H; Kowalski J; Duralska H; Murawska E Int J Dermatol; 1976 Nov; 15(9):688-9. PubMed ID: 977210 [TBL] [Abstract][Full Text] [Related]
4. Stimulation of lymphocytes in patients with psoriasis under photochemotherapy. A study of lymphocyte transformation. Wassilew SW Arch Dermatol Res; 1978 Nov; 263(2):127-34. PubMed ID: 736599 [TBL] [Abstract][Full Text] [Related]
5. Effect of 8-methoxypsoralen plus UVA (PUVA) on lymphocyte transformation and T cells in psoriatic patients. Fräki JE; Eskola J; Hopsu-Havu VK Br J Dermatol; 1979 May; 100(5):543-50. PubMed ID: 312653 [No Abstract] [Full Text] [Related]
6. Effects of 8-methoxypsoralen (8-MOP) and UVA on human lymphocytes. Lischka G; Bohnert E; Bächtold G; Jung EG Arch Dermatol Res (1975); 1977 Sep; 259(3):293-8. PubMed ID: 911195 [TBL] [Abstract][Full Text] [Related]
12. 8-MOP plasma levels in PUVA problem cases with psoriasis. Wagner G; Hofmann C; Busch U; Schmid J; Plewig G Br J Dermatol; 1979 Sep; 101(3):285-92. PubMed ID: 508594 [TBL] [Abstract][Full Text] [Related]
13. Effect of monochromatic UVA light and 8-methoxypsoralen on human lymphocyte response to mitogen. Gasparro FP; Berger CL; Edelson RL Photodermatol; 1984 Feb; 1(1):10-7. PubMed ID: 6531277 [TBL] [Abstract][Full Text] [Related]
14. Treatment of resistant psoriasis with oral 8-methoxypsoralen and longwave ultraviolet light (PUVA). A treatment schedule and a follow-up study. Weismann K; Howitz J; Bro-Jorgensen A Acta Derm Venereol; 1977; 57(1):73-6. PubMed ID: 74173 [TBL] [Abstract][Full Text] [Related]
15. Cancer incidence among Finnish psoriasis patients treated with 8-methoxypsoralen bath PUVA. Hannuksela-Svahn A; Pukkala E; Koulu L; Jansén CT; Karvonen J J Am Acad Dermatol; 1999 May; 40(5 Pt 1):694-6. PubMed ID: 10321595 [TBL] [Abstract][Full Text] [Related]
16. [Influence of retinoids on the bioavailability of methoxy-8-psoralen]. Beani JC; Bonnot D; Berthod F; Boitard M; Reymond JL; Beriel H; Amblard P Ann Dermatol Venereol; 1991; 118(4):273-5. PubMed ID: 2069337 [TBL] [Abstract][Full Text] [Related]
17. The mitotic index in psoriatic plaques and their response to PUVA therapy. Goldberg LH; Cox AJ; Abel EA Br J Dermatol; 1980 Apr; 102(4):401-5. PubMed ID: 7387882 [TBL] [Abstract][Full Text] [Related]
18. Bath-5-methoxypsoralen-UVA therapy for psoriasis. Calzavara-Pinton PG; Zane C; Carlino A; De Panfilis G J Am Acad Dermatol; 1997 Jun; 36(6 Pt 1):945-9. PubMed ID: 9204060 [TBL] [Abstract][Full Text] [Related]
19. UVA-induced inhibition of proliferation of PHA-stimulated lymphocytes from humans treated with 8-methoxypsoralen. Scherer R; Kern B; Braun-Falco O Br J Dermatol; 1977 Nov; 97(5):519-28. PubMed ID: 588465 [TBL] [Abstract][Full Text] [Related]
20. Treatment of psoriasis with psoralens and ultraviolet A. A double-blind comparison of 8-methoxypsoralen and 5-methoxypsoralen. Berg M; Ros AM Photodermatol Photoimmunol Photomed; 1994 Oct; 10(5):217-20. PubMed ID: 7880762 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]